Merck & Co. Inc. shares rose $3.85 to $50.21 on higher-than-expected first-quarter earnings. The drugmaker said it earned asmuch as 34 percent more than its forecasts. Also, the company wondismissal of lawsuits charging it defrauded investors beforewithdrawing Vioxx painkiller from the market in 2004.
Комментариев нет:
Отправить комментарий